Drug policy for an aging population--the European Medicines Agency's geriatric medicines strategy.
暂无分享,去创建一个
At the European Medicines Agency, the aging of the population has prompted an analysis of whether the regulatory system is adapted to taking the needs of older people into account in the development, approval, and use of medications.
[1] S. Studenski,et al. Gait speed and survival in older adults. , 2011, JAMA.
[2] Gül Büyükkılıç. Discrimination in the european union: A problem aimed to be resolved or just an instrument to serve the economic targets? , 2011 .
[3] J. Michel,et al. Fighting Against Age Discrimination in Clinical Trials , 2010, Journal of the American Geriatrics Society.